In patient-derived xenograft models of CRC with Fn enrichment, treatment with metronidazole reduced Fn load and impaired cancer cell proliferation and overall tumor growth, suggesting that Fn-abundant tumors may benefit from anti-fusobacterial therapy[72]. The gene discussed is FN1; the disease is colorectal carcinoma.